Plasma buprenorphine concentrations after the application of a 70 μg/h transdermal patch in dogs. Preliminary report

Journal of Veterinary Pharmacology and Therapeutics

Volumn 32, Issue 5, 2009, Pages 503-505

  Andaluz, A ^a   Moll, X ^a   Ventura, R ^b,c   Abellan R ^b,c   Fresno, L ^a   Garcia F ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; IODINE 125;

ABDOMEN; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CATHETER; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ANALGESICS, OPIOID; ANIMALS; BUPRENORPHINE; DOGS; MALE; RADIOIMMUNOASSAY;

ANIMALIA; CANIS FAMILIARIS;

EID: 70249151671     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2009.01058.x     Document Type: Article

References (12)

1. Andaluz, A., Moll, X., Fresno, L., Abellan, R., Ventura, R. García, F. (2008) Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs. Veterinary Journal, doi :.
2. Bartlett, A.J., Lloyd-Jones, J.G., Rance, M.J., Flockhart, I.R., Dockray, G.J., Bennett, M.R.D. Moore, R.A. (1980) The radioimmunoassay of Buprenorphine. Euopean Journal of Clinical Pharmacology, 18, 339 345.
3. Budd, K. (2002) Buprenorphine: a review. In Evidence Based Medicine in Practice. ed. Hayward Medical Communications, Kentford, UK. Available at: http://www.grunenthal.de/cw/de-DE/pdf/cw-de-de-budd-2002-buprenorphine-a-review. pdf. Accessed 12 January 2006.
4. Evans, H.C. Easthope, S.E. (2003) Transdermal buprenorphine. Drugs, 63, 1999 2010.
5. Martinez, E.A., Hartsfield, S.M., Melendez, L.D., Matthews, N.S. Slater, M.R. (1997) Cardiovascular effects of buprenorphine in anaesthetized dogs. American Journal of Veterinary Research, 58, 1280 1284.
6. Murrell, J.C., Robertson, S.A., Taylor, P.M., McCown, J.L., Bloomfield, M. Sear, J.W. (2007) Use of a transdermal matrix of buprenorphine in cats: preliminary pharmacokinetic and pharmacodynamic data. Veterinary Record, 160, 578 583.
7. Nolan, A., Livingstone, A. Waterman, A.E. (1987) Investigation of the antinociceptive activity of buprenorphine in sheep. British Journal of Pharmacology, 92, 527 533.
8. Papich, M.G. (2000) Pharmacologic considerations for opiate analgesic and nonsteroidal anti-inflammatory drugs. Veterinary Clinics of North America: Small Animal Practice, 30, 815 837.
9. Pascoe, P.J. (2000) Opioid analgesics. Veterinary Clinics of North America: Small Animal Practice, 30, 757 772.
10. Robertson, S.A., Lascelles, B.D., Taylor, P.M. Sear, J.W. (2005) PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration. Journal of Veterinary Pharmacology and Therapeutics, 28, 453 460.
11. Sorge, J. Sittl, R. (2004) Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Clinical Therapeutics, 26, 1808 1820.
12. Terlinden, R. Stadler, T. (2000) Pharmacokinetics Study on Single Application of the Buprenorphine Transdermal System (TDS). Grünenthal GmbII, P.O Box 500444, 52088 Aachen, Germany.